This resulted in the tumor sample failing to meet the sensitivity limit of the Oncomine Dx Target Test, the discordant results between the Oncomine Dx Target Test and the PNA‐LNA PCR clamp test, and the lack of response to EGFR‐TKI. This evidence concerns the gene EGFR and neoplasm.